Table of Contents
Advertisement
3.5. Carry-over
Carry-over was tested by analyzing samples with «High Concentrations» of WBC's, RBC's, HGB, and
PLT's. Each sample was analyzed in triplicate, followed by 3 background cycles. The % Carry-over is
calculated by using the following formula:
Carry-over = (Background1 - Background3)/(Sample3 - Background3) X 100
Parame
Tab.1-10:
Parameters units
WBC (10
Blood count Level
63.0
% Carry-over (Actual)
0.3
% Carry-over (Claimed) < 0.5%
3.6. Normal Ranges
These Normal ranges were established from a study performed in Somerville, NJ. (U.S.A.) This study
encompasses the central 95% of the values, in the distribution of 43 Normal, Healthy, and Drug Free
individuals. These Ranges are as followed:
)
Tab.1-11:
Parameters
3
3
WBC
(10
/mm
)
Lymphocytes (%)
Monocytes
(%)
Granulocytes (%)
6
3
RBC
(10
/mm
)
HGB
(g/dl)
HCT
(%)
3
MCV
(µm
)
MCH
(pg)
MCHC
(g/dl)
RDW
(%)
3
3
PLT
(10
/mm
)
3
MPV
(µm
)
PCT and PDW have not been established as indications for this product, in the United States. The
use of PCT and PDW should be restricted to Research Use Only.
Expected values will vary with sample population and/or geographical location. It is
highly recommended that each laboratory establish its own Normal ranges based upon
the local population!
3
3
6
3
/mm
) RBC (10
/mm
) HGB (g/dL)
7.58
0.00
<0.5%
Male (N=21)
Female (N=22)
4.7 - 9.6
4.9 - 12.3
23 - 47
19 - 41
3 - 6
2 - 6
49 - 74
53 - 79
4.37 - 5.63
3.90 - 5.10
13.5 - 16.5
12.0 - 15.0
41 - 50
37 - 45
83 - 101
84 - 96
26 - 34
27 - 34
32 - 35
32 - 35
12 - 16
12 - 14
145 - 355
150 - 330
7.3 - 9.0
8 - 10
ABX Micros
Specifications
Summary of Performance Data
3
PLT (10
/mm
23.4
988
0.0
0.0
<0.5%
<0.5%
60
- User Manual - RAB042FEN - 11
3
)
Advertisement
Chapters
Table of Contents
Troubleshooting
